France· FR:62154820
FINTEPLA 2,2 mg/mL, solution buvable
A medicinal product containing chlorhydrate de fenfluramine, registered in France by UCB PHARMA BELGIQUE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE FENFLURAMINE
- Manufacturer
- UCB PHARMA BELGIQUE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
3 priced- cip1334009302243591 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flaconEUR 462.34
- cip1334009302243661 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flaconEUR 899.59
- cip1334009302243731 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 360 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flaconEUR 2.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de fenfluramine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFINTEPLAUCB Pharma SA, Brusel
- SwitzerlandFintepla 2.2 mg/ml, solution buvableUCB-Pharma SA
- NorwayFinteplaUCB Pharma S.A.
- IrelandFintepla 2.2 mg/ml oral solutionUCB Pharma S.A.
- IcelandFinteplaUCB Pharma S.A.*
- NetherlandsFintepla 2,2 mg/ml drankUCB Pharma S.A.
- PolandFinteplaUCB Pharma S.A.
- SwedenFintepla 2,2 mg/ml Oral lösningUCB Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fintepla
- Liechtenstein · Fintepla
- Norway · Fintepla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d6d15d1-0a0e-4ec6-b80d-c482a21eeb9e GET /v1/drugs/1d6d15d1-0a0e-4ec6-b80d-c482a21eeb9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62154820",
"date_amm": "2020-12-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1491",
"substance": "CHLORHYDRATE DE FENFLURAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about chlorhydrate de fenfluramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.